|
|
 | | | |
- close
- close
- close
- close
| |||||||||
Chevron Corporation 8-K 2012
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2012
Chevron Corporation (Exact name of registrant as specified in its charter)
Registrant’s telephone number, including area code: (925) 842-1000 None (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
On December 5, 2012, Chevron Corporation (the “Corporation”) issued $2,000,000,000 in aggregate principal amount of 1.104% Notes Due 2017 (the “2017 Notes”) and $2,000,000,000 in aggregate principal amount of 2.355% Notes Due 2022 (the “2022 Notes” and, together with the 2017 Notes, the “Notes”). The Notes were issued pursuant to an Indenture (the “Indenture”), dated as of June 15, 1995, as supplemented by the Third Supplemental Indenture dated as of December 5, 2012 (the “Third Supplemental Indenture”), each being between the Corporation and Wells Fargo Bank, National Association, as trustee (the “Trustee”). On November 28, 2012, the Corporation entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Corporation agreed to issue and sell the Notes to the Underwriters. The provisions of the Underwriting Agreement are incorporated herein by reference. The 2017 Notes will mature on December 5, 2017, and the 2022 Notes will mature on December 5, 2022. The Corporation will pay interest on the Notes semiannually on June 5 and December 5 of each year starting on June 5, 2013. The Corporation will have the right to redeem the Notes in whole or in part at any time prior to maturity at the redemption price described in the Final Prospectus Supplement filed with the Securities and Exchange Commission on November 30, 2012 (Registration No. 333-184777) (the “Final Prospectus Supplement”). The Corporation has filed with the Securities and Exchange Commission a Prospectus dated November 6, 2012 (Registration No. 333-184777), a Preliminary Prospectus Supplement dated November 28, 2012, a Free Writing Prospectus dated November 28, 2012 and the Final Prospectus Supplement in connection with the public offering of the Notes. The descriptions of the Underwriting Agreement and the Third Supplemental Indenture are qualified in their entirety by the terms of such agreements themselves. Please refer to such agreements, and the form of 2017 Notes and the form of 2022 Notes, each of which is incorporated herein by reference and attached to this report as Exhibits 1.1, 4.1, and 4.2, respectively.
(d) Exhibits.
SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 5, 2012
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
